The purpose of this study was to assess predictors of developmental outcome at two years in VLBW infants. Five centers that participated in a multicenter randomized double-masked comparison trial of two surfactants (Exosurf and Infasurf) for the prophylaxis and treatment of respiratory distress syndrome were prospectively invited to participate in a four-year neurodevelopmental follow-up study. 299 infants received both Year 1 (Y1) and Year 2 (Y2) assessments using the Bayley scales, and neurodevelopmental examination performed by assessors masked to treatment. Outcomes were classified as Group 1: Bayley MDI and PDI >89. Group 2: MDI and/or PDI 70-89. Group 3: MDI or PDI 50-69. Group 4: MDI or PDI <50. Growth outcomes at one year were compared using WHO international reference curves and standardized as multiple of standard deviations from the mean (z score). 48% of infants did not change; 7% improved and 45% declined in developmental status between Y1 and Y2 (n = 287). Of 91 suspect children, 54% did not change, 12% improved and 34% declined. Conclusion: Children with CPVL, low maternal education, and microcephally at age Y1 were most likely to have severe neurodevelopmental disorders at age 2 years. Table

Table 1
Full size table

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account
Continue with Google
Continue with ORCiD